$CNAT Form 8-K

0
628
Biotech Stocks

Form 8-K for CONATUS PHARMACEUTICALS INC.


5-Mar-2015

Change in Directors or Principal Officers

Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.On March 2, 2015, Gary C. Burgess, M.B., Ch.B. M.Med., tendered his resignation as Senior Vice President, Clinical Research and Chief Medical Officer of Conatus Pharmaceuticals Inc., effective April 2, 2015.


 

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here